CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting.
| Image |  |
|---|---|
| Description | scientific article published on 6 January 2010 |
| Author/s |
author: Haakan Norell Yi Zhang |
| Publication date | January 6, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |